About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Mineralocorticoid Receptor in the Treatment of Severe Depression

Mineralocorticoid Receptor in the Treatment of Severe Depression

NCT00295347·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Universitätsklinikum Hamburg-Eppendorf

Age

18–70

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Depressed male and female inpatients according to DSM-IV
Age between 18 and 70 years
Minimum of 17-items Hamilton Depression Score of 18
Informed consent signed

You may not be if

Relevant medical or neurological disorders
Pregnancy or unsure contraception
Relevant psychiatric comorbidity
Active alcohol or other substance abuse/dependance
Contraindications to SSRI, fludrocortisone, or spironolactone
Steroid medication

The record

StatusCompleted

PhaseNo phase

Taking part65

StartedDec 2005

UpdatedMay 30, 2017

Conditions

Major Depression

Where1

University Hospital Hamburg-Eppendorf
Hamburg, Germany